Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratorios Liomont SA de CV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0491
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, antiviral, antibiotic, anti-inflammatory, antifungal, anti-obesity, cardiovascular, gastroenterology, anti-diabetics, respiratory, urological, musculoskeletal, gastrointestinal and cardiometabolic, among others. Liomont sells its products through a network of distributors in Mexico, Columbia, Dominican Republic, Equador, El Salvador, Guatemala, Panama, Peru and Venezuela. The company operates through its manufacturing facility located in Mexico. Liomont is headquartered in Mexico City, Mexico.

Laboratorios Liomont SA de CV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 10
Oncobiologics Enters into Licensing Agreement with Liomont to Develop Biosimilar Monoclonal Antibody 12
Laboratorios Liomont Enters into Licensing Agreement with Selexis 13
Laboratorios Liomont SA de CV – Key Competitors 14
Laboratorios Liomont SA de CV – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 10
Oncobiologics Enters into Licensing Agreement with Liomont to Develop Biosimilar Monoclonal Antibody 12
Laboratorios Liomont Enters into Licensing Agreement with Selexis 13
Laboratorios Liomont SA de CV, Key Competitors 14
Laboratorios Liomont SA de CV, Other Locations 15

List of Figures
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Numab Innovation AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Numab Innovation AG (Numab) is a developer of novel therapeutics for the treatment of severe diseases. The company’s pipeline products include ND007, ND009, ND016, ND017, ND023, ND026, and ND021. Its ND007 is a bispecific antibody fragment which is being evaluated for the treatment of autoim …
  • Axon Enterprise, Inc.:戦略・SWOT・企業財務分析
    Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report Summary Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Optum Inc-医療機器分野:企業M&A・提携分析
    Summary Optum Inc (Optum), a subsidiary of UnitedHealth Group Inc is a healthcare service provider that offers health IT, pharmacy care services, population health management, data and analytics, financial services, health care delivery, revenue cycle management, and health plan operations. The comp …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Paddy Power Betfair Plc:企業の戦略・SWOT・財務分析
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務情報
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ushdev International Limited (511736):企業の財務・戦略的SWOT分析
    Ushdev International Limited (511736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • International Paper Co:企業のM&A・事業提携・投資動向
    International Paper Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Paper Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Safe Orthopaedics SA (SAFOR):医療機器:M&Aディール及び事業提携情報
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Allightsykes Pty Ltd
    Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kvaerner ASA (KVAER):企業の財務・戦略的SWOT分析
    Kvaerner ASA (KVAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rocky Mountain Chocolate Factory, Inc.:企業の戦略・SWOT・財務情報
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PepsiCo Inc:戦略・SWOT・企業財務分析
    PepsiCo Inc - Strategy, SWOT and Corporate Finance Report Summary PepsiCo Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Chariot Oil & Gas Ltd (CHAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆